Legal & General Group
ACET icon

Legal & General Group’s Adicet Bio ACET Stock Holding History

Legal & General Group’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-296
Closed -$11.1K – 3413
2024
Q1 		$11.1K Buy
296
+125
+73% +$5.17K ﹤0.01% 3181
2023
Q4 		$5.17K Hold
171
– – ﹤0.01% 3322
2023
Q3 		$3.75K Hold
171
– – ﹤0.01% 3377
2023
Q2 		$6.65K Sell
171
-61
-26% -$5.38K ﹤0.01% 3361
2023
Q1 		$21.4K Sell
232
-255
-52% -$32K ﹤0.01% 3051
2022
Q4 		$69.7K Buy
487
+31
+7% +$7.74K ﹤0.01% 2890
2022
Q3 		$104K Buy
456
+59
+15% +$15K ﹤0.01% 2809
2022
Q2 		$93K Buy
397
+266
+203% +$58.4K ﹤0.01% 2875
2022
Q1 		$42K Buy
131
+27
+26% +$6.21K ﹤0.01% 3026
2021
Q4 		$29K Hold
104
– – ﹤0.01% 3156
2021
Q3 		$13K Hold
104
– – ﹤0.01% 3394
2021
Q2 		$17K Buy
+104
New +$21.2K ﹤0.01% 3340
2020
Q2 		– Sell
-22
Closed -$3K – 3404
2020
Q1 		$3K Hold
22
– – ﹤0.01% 3305
2019
Q4 		$4K Hold
22
– – ﹤0.01% 3345
2019
Q3 		$22K Hold
22
– – ﹤0.01% 3100
2019
Q2 		$26K Buy
22
+12
+120% +$10.9K ﹤0.01% 3098
2019
Q1 		$8K Hold
10
– – ﹤0.01% 3272
2018
Q4 		$10K Hold
10
– – ﹤0.01% 3270
2018
Q3 		$17K Hold
10
– – ﹤0.01% 3243
2018
Q2 		$10K Hold
10
– – ﹤0.01% 3296
2018
Q1 		$11K Buy
+10
New +$18.3K ﹤0.01% 3206

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Legal & General Group's ACET Position: Q2 2024 in Review

Legal & General Group sold out of Adicet Bio (ACET) in Q2 2024, closing a stake of 296 shares — an estimated $11.1K sold.

Legal & General Group first reported a position in ACET in Q1 2018 and held it in 21 quarters. The position peaked at $104K in Q3 2022. 86 funds tracked by Wall St. Rank hold ACET as of Q2 2024.

  • Legal & General Group reported no remaining Adicet Bio position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 296 Adicet Bio shares in Q2 2024, an estimated $11.1K.
  • Legal & General Group first reported a position in Adicet Bio in Q1 2018 and held it in 21 quarters.
  • Legal & General Group's Adicet Bio position peaked at $104K in Q3 2022.
  • 86 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.